| PERIOD ENDING | 31-Mar-09 | 27-Jun-08 | 31-Mar-08 | | Total Revenue | 35 | 84 | 84 | | Cost of Revenue | 546 | 386 | 386 | | | Gross Profit | (511) | (303) | (303) | | | Operating Expenses | | Research Development | 297 | 166 | 166 | | Selling General and Administrative | 2,387 | 2,551 | 2,551 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (3,196) | (3,020) | (3,020) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (10,814) | 50 | 50 | | Earnings Before Interest And Taxes | (14,010) | (2,970) | (2,970) | | Interest Expense | 2,693 | 1,593 | 1,593 | | Income Before Tax | (16,704) | (4,562) | (4,562) | | Income Tax Expense | 2 | 2 | 2 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (16,705) | (4,564) | (4,564) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (16,705) | (4,564) | (4,564) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($16,705) | ($4,564) | ($4,564) |
|
0.63% Nasdaq 
0.03%
Income Statement
